1.
Role of 18F-FDG PET/CT scan and MRI for Predicting Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer Management. Bangladesh J. Nuclear Med. 2025;28(1):22-30. doi:10.3329/bjnm.v28i1.79482